Hideki Tokaibayashi
Director/Board Member at TELLA, INC.
Hideki Tokaibayashi active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TELLA, INC. | Director/Board Member | 2021-02-28 | - |
| GranCharite Co. Ltd. | Director/Board Member | 2017-10-31 | - |
Career history of Hideki Tokaibayashi
Former positions of Hideki Tokaibayashi
| Companies | Position | Start | End |
|---|---|---|---|
| REMIXPOINT, INC. | Director/Board Member | 2020-05-31 | 2022-06-27 |
| Independent Dir/Board Member | 2020-05-31 | 2022-06-27 |
Statistics
International
| Japan | 4 |
Operational
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
Sectoral
| Technology Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| REMIXPOINT, INC. | Technology Services |
| Private companies | 2 |
|---|---|
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
| GranCharite Co. Ltd. |
- Stock Market
- Insiders
- Hideki Tokaibayashi
- Experience
